Atlas Trials

Gastroenteropancreatic Neuroendocrine Tumor

23 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Gastroenteropancreatic Neuroendocrine Tumor

RecordFirmDate
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy (NCT05477576)RayzeBio, Inc.2022-03-24
Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs (NCT04852679)Ipsen2021-05-24
Study of PRRT in Metastatic, WHO Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery (NCT04609592)Stanford University2021-03-17
Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs (NCT04727723)Novartis Pharmaceuticals2021-03-09
Nutrition in Gastroenteropancreatic Neuroendocrine Tumor (NCT04986085)Grupo Espanol de Tumores Neuroendocrinos2021-02-24
Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin. (NCT03980925)Grupo Espanol de Tumores Neuroendocrinos2019-10-11
68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours (NCT06155318)IRCCS San Raffaele2019-09-05
Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) (NCT03017690)Ipsen2017-04-12
Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors (NCT02948946)H. Lee Moffitt Cancer Center and Research Institute2017-01-09
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors (NCT02611024)PharmaMar2016-05-06
A Study of Famitinib in Patients With Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumor (NCT01994213)Jiangsu HengRui Medicine Co., Ltd.2011-10-01

Track Gastroenteropancreatic Neuroendocrine Tumor automatically

Every clearance here is in the API, with alerts when new ones post.